← All trials
NCT05501418
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 5, 2020
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Aug 15, 2022
- Last posted
- Aug 15, 2022
- Enrollment
- 75
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Ever Supreme Bio Technology Co., Ltd.Lead sponsor
- China Medical UniversityOverall official - principal investigator
- Ever Supreme Bio Technology Co., Ltd.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.